BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 11488062)

  • 1. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
    Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
    Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
    Liu XY; Atkins RC; Feusner JH; Rowland JM
    Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
    Camera A; Pezzullo L; Villa MR; Luciano L; Pane F; Izzo B; Boccuni P; Di Noto R; Del Vecchio L; Salvatore F; Rotoli B
    Haematologica; 2000 May; 85(5):496-501. PubMed ID: 10800166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
    Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
    Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping of mature T/NK cell neoplasm presenting as leukemia.
    Gujral S; Polampalli S; Badrinath Y; Kumar A; Subramanian PG; Nair R; Sengar M; Nair C
    Indian J Cancer; 2010; 47(2):189-93. PubMed ID: 20448385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
    Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK
    Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
    Tai YC; Kim LH; Peh SC
    Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma].
    Zhong BN; Zhang XH; Li M; Cao HG; Li N; Liu CY; Gu YQ; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):505-9. PubMed ID: 14690577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.